Gene Symbol | Gene ID | Gene Info |
---|---|---|
PPARG
|
ENSG00000132170.15 | peroxisome proliferator activated receptor gamma |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr3_12395833_12395984 | PPARG | 2937 | 0.349675 | -0.93 | 3.1e-04 | Click! |
chr3_12266121_12266272 | PPARG | 62671 | 0.122427 | -0.82 | 6.6e-03 | Click! |
chr3_12377941_12378223 | PPARG | 14889 | 0.256190 | 0.74 | 2.4e-02 | Click! |
chr3_12422682_12422833 | PPARG | 29786 | 0.196860 | 0.73 | 2.5e-02 | Click! |
chr3_12276997_12277148 | PPARG | 51795 | 0.150660 | -0.72 | 2.8e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_99819712_99820188 | 1.09 |
ENSG00000222482 |
. |
2207 |
0.15 |
chr3_187696515_187696882 | 1.07 |
LPP |
LIM domain containing preferred translocation partner in lipoma |
174374 |
0.03 |
chr7_148981019_148981379 | 0.86 |
ZNF783 |
zinc finger family member 783 |
1203 |
0.36 |
chr7_2739468_2739742 | 0.75 |
AMZ1 |
archaelysin family metallopeptidase 1 |
11769 |
0.21 |
chr1_202132763_202133787 | 0.72 |
PTPN7 |
protein tyrosine phosphatase, non-receptor type 7 |
2559 |
0.21 |
chr11_65408846_65409255 | 0.70 |
SIPA1 |
signal-induced proliferation-associated 1 |
751 |
0.41 |
chr19_49838163_49838543 | 0.66 |
CD37 |
CD37 molecule |
300 |
0.78 |
chr11_6424420_6425308 | 0.66 |
APBB1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
1030 |
0.44 |
chr9_137367972_137368123 | 0.66 |
RXRA |
retinoid X receptor, alpha |
69619 |
0.11 |
chr16_57168390_57168643 | 0.61 |
CPNE2 |
copine II |
15405 |
0.14 |
chr14_98676295_98676520 | 0.58 |
ENSG00000222066 |
. |
121680 |
0.06 |
chr14_100546662_100546850 | 0.58 |
CTD-2376I20.1 |
|
5541 |
0.16 |
chr16_79313034_79313388 | 0.57 |
ENSG00000222244 |
. |
14860 |
0.29 |
chr11_12378207_12378574 | 0.57 |
ENSG00000264283 |
. |
12076 |
0.19 |
chr16_88545798_88545998 | 0.56 |
ENSG00000263456 |
. |
10572 |
0.17 |
chr11_121351250_121351763 | 0.56 |
RP11-730K11.1 |
|
27784 |
0.21 |
chr12_133064825_133065258 | 0.55 |
FBRSL1 |
fibrosin-like 1 |
1096 |
0.54 |
chr16_50308946_50309418 | 0.55 |
ADCY7 |
adenylate cyclase 7 |
1118 |
0.53 |
chr12_113527618_113527818 | 0.54 |
DTX1 |
deltex homolog 1 (Drosophila) |
32223 |
0.11 |
chr21_32549988_32550321 | 0.54 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
47615 |
0.18 |
chr11_73716797_73717380 | 0.53 |
UCP3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
1261 |
0.4 |
chr3_33095798_33096165 | 0.53 |
GLB1 |
galactosidase, beta 1 |
42303 |
0.12 |
chr3_33094206_33094581 | 0.53 |
GLB1 |
galactosidase, beta 1 |
43891 |
0.12 |
chrX_152603368_152603519 | 0.52 |
ZNF275 |
zinc finger protein 275 |
3830 |
0.2 |
chr10_15227195_15227346 | 0.52 |
NMT2 |
N-myristoyltransferase 2 |
16578 |
0.2 |
chr10_6571440_6571602 | 0.52 |
PRKCQ |
protein kinase C, theta |
50680 |
0.18 |
chr1_206755327_206755741 | 0.52 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
25041 |
0.13 |
chr22_45016760_45017091 | 0.51 |
PRR5 |
proline rich 5 (renal) |
47668 |
0.15 |
chr3_14924290_14924594 | 0.51 |
FGD5 |
FYVE, RhoGEF and PH domain containing 5 |
61503 |
0.1 |
chr8_81289205_81289813 | 0.51 |
ENSG00000252884 |
. |
28242 |
0.19 |
chr17_38762219_38762396 | 0.51 |
SMARCE1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 |
26235 |
0.12 |
chr17_72751609_72751889 | 0.51 |
SLC9A3R1 |
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 |
6393 |
0.1 |
chr6_167533760_167534243 | 0.50 |
CCR6 |
chemokine (C-C motif) receptor 6 |
2256 |
0.3 |
chr3_177360373_177360796 | 0.50 |
ENSG00000200288 |
. |
18387 |
0.29 |
chr20_57723964_57724434 | 0.50 |
ZNF831 |
zinc finger protein 831 |
41876 |
0.16 |
chr17_76128893_76129294 | 0.50 |
TMC6 |
transmembrane channel-like 6 |
605 |
0.58 |
chr2_122496335_122496524 | 0.50 |
TSN |
translin |
1750 |
0.3 |
chr11_1781297_1781822 | 0.49 |
AC068580.6 |
|
19 |
0.92 |
chr20_39775264_39775450 | 0.49 |
RP1-1J6.2 |
|
8714 |
0.2 |
chr14_106453805_106454306 | 0.49 |
IGHV1-2 |
immunoglobulin heavy variable 1-2 |
885 |
0.24 |
chr19_17112962_17113366 | 0.49 |
CTD-2528A14.1 |
|
6835 |
0.15 |
chr5_133467358_133467605 | 0.49 |
TCF7 |
transcription factor 7 (T-cell specific, HMG-box) |
8172 |
0.21 |
chr20_31123380_31123862 | 0.49 |
C20orf112 |
chromosome 20 open reading frame 112 |
579 |
0.74 |
chr7_2739159_2739434 | 0.48 |
AMZ1 |
archaelysin family metallopeptidase 1 |
11460 |
0.21 |
chr3_15503071_15503367 | 0.48 |
EAF1-AS1 |
EAF1 antisense RNA 1 |
10110 |
0.12 |
chr19_49902085_49902258 | 0.48 |
CCDC155 |
coiled-coil domain containing 155 |
4371 |
0.08 |
chr14_61850578_61851088 | 0.48 |
PRKCH |
protein kinase C, eta |
6579 |
0.26 |
chr7_8171333_8171763 | 0.48 |
AC006042.6 |
|
17893 |
0.2 |
chr2_113944916_113945243 | 0.47 |
PSD4 |
pleckstrin and Sec7 domain containing 4 |
8778 |
0.14 |
chr11_67173408_67173659 | 0.47 |
TBC1D10C |
TBC1 domain family, member 10C |
1873 |
0.13 |
chr5_35852211_35852414 | 0.47 |
IL7R |
interleukin 7 receptor |
485 |
0.82 |
chr10_3462118_3462297 | 0.47 |
PITRM1 |
pitrilysin metallopeptidase 1 |
247204 |
0.02 |
chr10_29969072_29969239 | 0.47 |
ENSG00000222092 |
. |
31689 |
0.18 |
chr19_51627416_51627752 | 0.47 |
SIGLEC9 |
sialic acid binding Ig-like lectin 9 |
581 |
0.56 |
chr5_156644403_156644620 | 0.47 |
CTB-4E7.1 |
|
6879 |
0.14 |
chr1_160535323_160535488 | 0.47 |
CD84 |
CD84 molecule |
13858 |
0.13 |
chr22_18258720_18259014 | 0.46 |
BID |
BH3 interacting domain death agonist |
1436 |
0.41 |
chr3_46390356_46390605 | 0.46 |
CCR2 |
chemokine (C-C motif) receptor 2 |
4745 |
0.2 |
chr22_37543853_37544124 | 0.46 |
IL2RB |
interleukin 2 receptor, beta |
2042 |
0.21 |
chr1_25252459_25252702 | 0.46 |
RUNX3 |
runt-related transcription factor 3 |
3032 |
0.3 |
chr5_1313612_1313923 | 0.46 |
ENSG00000263670 |
. |
4275 |
0.2 |
chr12_121473450_121473650 | 0.46 |
OASL |
2'-5'-oligoadenylate synthetase-like |
3200 |
0.19 |
chr4_40218742_40218915 | 0.45 |
RHOH |
ras homolog family member H |
16864 |
0.21 |
chr22_27040168_27040347 | 0.45 |
CRYBA4 |
crystallin, beta A4 |
22329 |
0.17 |
chr10_73863981_73864132 | 0.45 |
SPOCK2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
15266 |
0.2 |
chr6_33873520_33874114 | 0.45 |
ENSG00000221697 |
. |
94011 |
0.06 |
chr20_43277539_43277694 | 0.45 |
ADA |
adenosine deaminase |
2716 |
0.2 |
chr21_46338509_46338732 | 0.44 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
2150 |
0.17 |
chr19_16467370_16467664 | 0.44 |
EPS15L1 |
epidermal growth factor receptor pathway substrate 15-like 1 |
5247 |
0.16 |
chr17_999891_1000162 | 0.44 |
ABR |
active BCR-related |
12314 |
0.2 |
chr6_5522387_5522696 | 0.44 |
RP1-232P20.1 |
|
64233 |
0.14 |
chr1_207090489_207090800 | 0.44 |
FAIM3 |
Fas apoptotic inhibitory molecule 3 |
4568 |
0.17 |
chr14_101106211_101106459 | 0.44 |
CTD-2644I21.1 |
|
50672 |
0.08 |
chr7_149565914_149566574 | 0.44 |
ATP6V0E2 |
ATPase, H+ transporting V0 subunit e2 |
3813 |
0.19 |
chr5_175956521_175957004 | 0.44 |
RNF44 |
ring finger protein 44 |
884 |
0.47 |
chr3_46416206_46416357 | 0.44 |
CCR5 |
chemokine (C-C motif) receptor 5 (gene/pseudogene) |
2120 |
0.26 |
chr8_134067708_134067917 | 0.43 |
SLA |
Src-like-adaptor |
4791 |
0.28 |
chr1_154238433_154238584 | 0.43 |
ENSG00000201129 |
. |
6305 |
0.08 |
chr10_4170376_4170710 | 0.43 |
KLF6 |
Kruppel-like factor 6 |
343070 |
0.01 |
chr7_148325963_148326351 | 0.43 |
C7orf33 |
chromosome 7 open reading frame 33 |
38500 |
0.16 |
chr5_110564408_110564849 | 0.43 |
CAMK4 |
calcium/calmodulin-dependent protein kinase IV |
4844 |
0.26 |
chr7_38407986_38408314 | 0.43 |
AMPH |
amphiphysin |
94563 |
0.09 |
chr16_30392632_30392982 | 0.43 |
SEPT1 |
septin 1 |
945 |
0.31 |
chr14_22974081_22974308 | 0.43 |
TRAJ51 |
T cell receptor alpha joining 51 (pseudogene) |
18023 |
0.09 |
chr9_132345350_132345729 | 0.43 |
RP11-492E3.2 |
|
7851 |
0.14 |
chr9_130623880_130624317 | 0.43 |
ENG |
endoglin |
7063 |
0.08 |
chr9_95834544_95834805 | 0.42 |
SUSD3 |
sushi domain containing 3 |
3292 |
0.21 |
chr1_158899632_158899783 | 0.42 |
PYHIN1 |
pyrin and HIN domain family, member 1 |
879 |
0.64 |
chr4_1237782_1238175 | 0.42 |
CTBP1 |
C-terminal binding protein 1 |
2267 |
0.22 |
chr1_25248232_25248398 | 0.42 |
RUNX3 |
runt-related transcription factor 3 |
7297 |
0.24 |
chr17_47814433_47814907 | 0.42 |
FAM117A |
family with sequence similarity 117, member A |
12781 |
0.14 |
chr3_46005175_46005371 | 0.42 |
FYCO1 |
FYVE and coiled-coil domain containing 1 |
5120 |
0.19 |
chr14_91858369_91858695 | 0.42 |
CCDC88C |
coiled-coil domain containing 88C |
25158 |
0.2 |
chr15_32651213_32651761 | 0.42 |
ENSG00000221444 |
. |
34186 |
0.1 |
chr2_235334226_235334544 | 0.42 |
ARL4C |
ADP-ribosylation factor-like 4C |
70859 |
0.14 |
chr8_125575470_125576116 | 0.42 |
MTSS1 |
metastasis suppressor 1 |
2175 |
0.26 |
chr22_23268788_23268939 | 0.42 |
IGLJ7 |
immunoglobulin lambda joining 7 |
5301 |
0.07 |
chr16_57163028_57163387 | 0.42 |
CPNE2 |
copine II |
10096 |
0.15 |
chr1_207633000_207633151 | 0.42 |
CR2 |
complement component (3d/Epstein Barr virus) receptor 2 |
5365 |
0.23 |
chr17_39496825_39497026 | 0.42 |
KRT33A |
keratin 33A |
10139 |
0.08 |
chr2_102984737_102985012 | 0.41 |
IL18R1 |
interleukin 18 receptor 1 |
5753 |
0.19 |
chr8_125574992_125575143 | 0.41 |
MTSS1 |
metastasis suppressor 1 |
2901 |
0.21 |
chr19_16228666_16229162 | 0.41 |
RAB8A |
RAB8A, member RAS oncogene family |
6207 |
0.14 |
chr3_46411260_46411477 | 0.41 |
CCR5 |
chemokine (C-C motif) receptor 5 (gene/pseudogene) |
265 |
0.9 |
chr2_28572176_28572390 | 0.41 |
AC093690.1 |
|
38957 |
0.13 |
chr1_9778118_9778444 | 0.41 |
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
154 |
0.95 |
chr14_22565547_22565859 | 0.41 |
ENSG00000238634 |
. |
45184 |
0.18 |
chr20_2723372_2723744 | 0.41 |
EBF4 |
early B-cell factor 4 |
36671 |
0.09 |
chr2_241503761_241504027 | 0.40 |
RNPEPL1 |
arginyl aminopeptidase (aminopeptidase B)-like 1 |
1327 |
0.3 |
chr16_68403491_68403775 | 0.40 |
SMPD3 |
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) |
1275 |
0.35 |
chr17_37252182_37252943 | 0.40 |
PLXDC1 |
plexin domain containing 1 |
11178 |
0.15 |
chr14_21136496_21136717 | 0.40 |
ENSG00000199461 |
. |
10964 |
0.09 |
chr6_160436305_160436759 | 0.40 |
AIRN |
antisense of IGF2R non-protein coding RNA |
7836 |
0.24 |
chr1_59407152_59407509 | 0.40 |
JUN |
jun proto-oncogene |
157545 |
0.04 |
chr17_81146535_81146986 | 0.40 |
METRNL |
meteorin, glial cell differentiation regulator-like |
94766 |
0.08 |
chr9_134143505_134143979 | 0.40 |
FAM78A |
family with sequence similarity 78, member A |
2138 |
0.29 |
chr4_40305683_40306008 | 0.40 |
CHRNA9 |
cholinergic receptor, nicotinic, alpha 9 (neuronal) |
31501 |
0.18 |
chr4_40219694_40220159 | 0.40 |
RHOH |
ras homolog family member H |
17962 |
0.21 |
chr1_25253582_25253853 | 0.40 |
RUNX3 |
runt-related transcription factor 3 |
1895 |
0.39 |
chr6_112114827_112115099 | 0.39 |
FYN |
FYN oncogene related to SRC, FGR, YES |
126 |
0.98 |
chr1_776644_776929 | 0.39 |
RP11-206L10.8 |
|
31245 |
0.11 |
chr6_159519924_159520304 | 0.39 |
TAGAP |
T-cell activation RhoGTPase activating protein |
53930 |
0.11 |
chr19_42377110_42377408 | 0.39 |
CD79A |
CD79a molecule, immunoglobulin-associated alpha |
3931 |
0.13 |
chr17_46498324_46498623 | 0.39 |
SKAP1 |
src kinase associated phosphoprotein 1 |
9079 |
0.14 |
chr16_89762947_89763492 | 0.39 |
SPATA2L |
spermatogenesis associated 2-like |
4829 |
0.1 |
chr11_46352086_46352730 | 0.39 |
DGKZ |
diacylglycerol kinase, zeta |
2047 |
0.27 |
chr19_13213848_13214497 | 0.39 |
LYL1 |
lymphoblastic leukemia derived sequence 1 |
197 |
0.89 |
chr7_150359146_150359387 | 0.39 |
GIMAP2 |
GTPase, IMAP family member 2 |
23522 |
0.15 |
chr22_36684429_36684580 | 0.39 |
ENSG00000266345 |
. |
27742 |
0.14 |
chr1_27165220_27165588 | 0.39 |
ZDHHC18 |
zinc finger, DHHC-type containing 18 |
6893 |
0.12 |
chr14_99450232_99450383 | 0.39 |
AL162151.4 |
|
174446 |
0.03 |
chr2_197048030_197048186 | 0.39 |
STK17B |
serine/threonine kinase 17b |
6881 |
0.2 |
chr1_228072467_228072618 | 0.39 |
ENSG00000264483 |
. |
56842 |
0.1 |
chr2_74248551_74248821 | 0.38 |
TET3 |
tet methylcytosine dioxygenase 3 |
18846 |
0.16 |
chr17_35085631_35085782 | 0.38 |
MRM1 |
mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae) |
127315 |
0.04 |
chr10_26768891_26769074 | 0.38 |
ENSG00000199733 |
. |
29536 |
0.21 |
chr15_70550046_70550380 | 0.38 |
ENSG00000200216 |
. |
64638 |
0.14 |
chr9_4596090_4596285 | 0.38 |
SLC1A1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
23852 |
0.19 |
chrX_128904932_128905357 | 0.38 |
SASH3 |
SAM and SH3 domain containing 3 |
8816 |
0.2 |
chr1_54946013_54946309 | 0.38 |
ENSG00000265404 |
. |
24180 |
0.16 |
chr11_119235370_119235524 | 0.38 |
USP2 |
ubiquitin specific peptidase 2 |
530 |
0.59 |
chr16_31707620_31707947 | 0.38 |
CLUHP3 |
clustered mitochondria (cluA/CLU1) homolog pseudogene 3 |
6706 |
0.17 |
chr3_68135261_68135467 | 0.38 |
FAM19A1 |
family with sequence similarity 19 (chemokine (C-C motif)-like), member A1 |
79991 |
0.12 |
chr6_149381041_149381264 | 0.38 |
RP11-162J8.3 |
|
27443 |
0.22 |
chr20_25022537_25022783 | 0.38 |
ACSS1 |
acyl-CoA synthetase short-chain family member 1 |
9321 |
0.2 |
chr11_60877401_60877552 | 0.38 |
CD5 |
CD5 molecule |
7495 |
0.18 |
chr2_47173162_47173468 | 0.38 |
MCFD2 |
multiple coagulation factor deficiency 2 |
4321 |
0.17 |
chr14_22947374_22947525 | 0.38 |
TRAJ60 |
T cell receptor alpha joining 60 (pseudogene) |
2153 |
0.16 |
chr2_74258310_74258513 | 0.38 |
TET3 |
tet methylcytosine dioxygenase 3 |
15039 |
0.17 |
chr2_233950353_233950744 | 0.38 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
25359 |
0.17 |
chr18_29563540_29563829 | 0.38 |
RNF125 |
ring finger protein 125, E3 ubiquitin protein ligase |
34651 |
0.11 |
chr6_35279762_35280244 | 0.37 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
2488 |
0.27 |
chr2_68961132_68961308 | 0.37 |
ARHGAP25 |
Rho GTPase activating protein 25 |
693 |
0.77 |
chr20_57758094_57758324 | 0.37 |
ZNF831 |
zinc finger protein 831 |
7866 |
0.26 |
chr10_71318212_71318363 | 0.37 |
NEUROG3 |
neurogenin 3 |
14707 |
0.18 |
chrX_153582032_153582208 | 0.37 |
FLNA |
filamin A, alpha |
583 |
0.57 |
chr1_11802035_11802206 | 0.37 |
AGTRAP |
angiotensin II receptor-associated protein |
5888 |
0.13 |
chr16_3857767_3857985 | 0.37 |
CREBBP |
CREB binding protein |
27008 |
0.19 |
chr12_674006_674157 | 0.37 |
RP5-1154L15.2 |
|
21571 |
0.13 |
chr16_57021435_57021712 | 0.37 |
NLRC5 |
NLR family, CARD domain containing 5 |
1837 |
0.25 |
chr14_98637898_98638078 | 0.37 |
ENSG00000222066 |
. |
160099 |
0.04 |
chr1_20015357_20015517 | 0.37 |
HTR6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
23657 |
0.16 |
chr12_40023753_40023976 | 0.37 |
C12orf40 |
chromosome 12 open reading frame 40 |
3879 |
0.28 |
chr10_121297891_121298084 | 0.37 |
RGS10 |
regulator of G-protein signaling 10 |
1942 |
0.4 |
chr18_2967412_2967563 | 0.37 |
RP11-737O24.1 |
|
471 |
0.77 |
chr9_140347294_140347548 | 0.37 |
NSMF |
NMDA receptor synaptonuclear signaling and neuronal migration factor |
1523 |
0.27 |
chr18_68307691_68307842 | 0.37 |
GTSCR1 |
Gilles de la Tourette syndrome chromosome region, candidate 1 |
10181 |
0.31 |
chr3_56952065_56952464 | 0.37 |
ARHGEF3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
1765 |
0.42 |
chr10_89953557_89953785 | 0.37 |
ENSG00000200891 |
. |
199219 |
0.03 |
chr9_70938018_70938169 | 0.37 |
FOXD4L3 |
forkhead box D4-like 3 |
20817 |
0.15 |
chr9_35910713_35911016 | 0.37 |
HRCT1 |
histidine rich carboxyl terminus 1 |
4675 |
0.15 |
chr2_106478965_106479116 | 0.37 |
AC009505.2 |
|
5407 |
0.26 |
chr10_6079510_6080013 | 0.36 |
IL2RA |
interleukin 2 receptor, alpha |
11797 |
0.14 |
chr9_96030770_96030921 | 0.36 |
WNK2 |
WNK lysine deficient protein kinase 2 |
4615 |
0.26 |
chr1_27160442_27160760 | 0.36 |
ZDHHC18 |
zinc finger, DHHC-type containing 18 |
2090 |
0.2 |
chr10_43790753_43790904 | 0.36 |
RASGEF1A |
RasGEF domain family, member 1A |
28461 |
0.17 |
chr10_9137729_9137996 | 0.36 |
ENSG00000212505 |
. |
439068 |
0.01 |
chr16_89041472_89041726 | 0.36 |
CBFA2T3 |
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
1802 |
0.3 |
chr12_3857026_3857275 | 0.36 |
EFCAB4B |
EF-hand calcium binding domain 4B |
5113 |
0.26 |
chr17_9372400_9372551 | 0.36 |
RP11-565F19.4 |
|
4416 |
0.22 |
chr11_722284_722581 | 0.36 |
AP006621.9 |
|
4615 |
0.09 |
chr1_27072713_27073114 | 0.36 |
ARID1A |
AT rich interactive domain 1A (SWI-like) |
17042 |
0.12 |
chr1_111179224_111179419 | 0.36 |
KCNA2 |
potassium voltage-gated channel, shaker-related subfamily, member 2 |
5225 |
0.2 |
chr11_4113400_4113717 | 0.36 |
RRM1 |
ribonucleotide reductase M1 |
2481 |
0.29 |
chr4_2817440_2817610 | 0.36 |
SH3BP2 |
SH3-domain binding protein 2 |
2387 |
0.3 |
chr11_73715681_73716026 | 0.36 |
UCP3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
2496 |
0.23 |
chr10_51503497_51503779 | 0.36 |
AGAP7 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 7 |
17311 |
0.19 |
chr1_247570539_247571127 | 0.36 |
NLRP3 |
NLR family, pyrin domain containing 3 |
8625 |
0.18 |
chr1_169670629_169671082 | 0.36 |
SELL |
selectin L |
9984 |
0.2 |
chr7_151125685_151126226 | 0.36 |
RP4-555L14.4 |
|
1186 |
0.33 |
chr19_4088417_4088592 | 0.36 |
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
12541 |
0.11 |
chr20_31169576_31169970 | 0.36 |
RP11-410N8.1 |
|
8 |
0.97 |
chr4_2365742_2365893 | 0.36 |
ZFYVE28 |
zinc finger, FYVE domain containing 28 |
714 |
0.67 |
chr3_43386732_43386964 | 0.36 |
RP11-188P20.3 |
|
2287 |
0.28 |
chr1_1073051_1073561 | 0.36 |
C1orf159 |
chromosome 1 open reading frame 159 |
21565 |
0.08 |
chr3_128736783_128736934 | 0.36 |
EFCC1 |
EF-hand and coiled-coil domain containing 1 |
16386 |
0.13 |
chr15_81608011_81608276 | 0.36 |
STARD5 |
StAR-related lipid transfer (START) domain containing 5 |
8323 |
0.18 |
chr14_23011658_23011809 | 0.35 |
TRAJ15 |
T cell receptor alpha joining 15 |
13153 |
0.1 |
chr14_61903705_61903865 | 0.35 |
PRKCH |
protein kinase C, eta |
5491 |
0.27 |
chr19_8774866_8775027 | 0.35 |
ACTL9 |
actin-like 9 |
34226 |
0.15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 1.2 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.2 | 0.6 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.2 | 0.6 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.2 | 0.2 | GO:0034112 | positive regulation of homotypic cell-cell adhesion(GO:0034112) |
0.2 | 0.5 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.2 | 0.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 0.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 0.6 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.1 | 0.4 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.1 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.1 | 0.4 | GO:0061526 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.1 | 0.4 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.2 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.1 | 0.5 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.5 | GO:1901339 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.7 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.1 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 0.6 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.3 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.1 | 0.4 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.1 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.3 | GO:0043301 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.1 | 0.5 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 0.5 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.3 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.3 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.3 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.3 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 0.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.3 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.5 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.3 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.9 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.8 | GO:0051828 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.1 | 0.2 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.1 | 0.1 | GO:0002666 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
0.1 | 1.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.2 | GO:0002335 | mature B cell differentiation involved in immune response(GO:0002313) mature B cell differentiation(GO:0002335) |
0.1 | 0.2 | GO:0032661 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
0.1 | 2.0 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.1 | 0.1 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.1 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.5 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.2 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.3 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.1 | 0.1 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.1 | 0.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.5 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.1 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.2 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.1 | 1.0 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.3 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.1 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.2 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.1 | 0.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.1 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.1 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.3 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.1 | 0.3 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.1 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.3 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.2 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.1 | 0.2 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.1 | 0.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.1 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.1 | 0.1 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.1 | 0.1 | GO:0071503 | response to heparin(GO:0071503) |
0.1 | 0.6 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.4 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.2 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.1 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.1 | 0.3 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 0.2 | GO:0001845 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.1 | 0.2 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.2 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.1 | 0.2 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.7 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 0.1 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.1 | 0.2 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.6 | GO:0000303 | response to superoxide(GO:0000303) |
0.0 | 0.2 | GO:0035751 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.1 | GO:0001820 | serotonin secretion(GO:0001820) |
0.0 | 0.1 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.0 | 1.5 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.0 | 0.1 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.0 | 0.4 | GO:0060039 | pericardium development(GO:0060039) |
0.0 | 0.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.6 | GO:0002637 | regulation of immunoglobulin production(GO:0002637) |
0.0 | 0.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.1 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.0 | 0.0 | GO:0072540 | T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) T-helper 17 type immune response(GO:0072538) T-helper 17 cell differentiation(GO:0072539) T-helper 17 cell lineage commitment(GO:0072540) regulation of T-helper 17 type immune response(GO:2000316) positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 17 cell differentiation(GO:2000319) positive regulation of T-helper 17 cell differentiation(GO:2000321) regulation of T-helper 17 cell lineage commitment(GO:2000328) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.0 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.2 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.0 | 0.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.1 | GO:1903306 | negative regulation of regulated secretory pathway(GO:1903306) |
0.0 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.6 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.2 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.0 | GO:0070933 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.2 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.0 | 0.3 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.0 | 0.1 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.5 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.0 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0072583 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.0 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.0 | 0.1 | GO:0035268 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.0 | 0.3 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.2 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.0 | 0.0 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 | 0.4 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.0 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.0 | 0.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.1 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.0 | 0.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.0 | 0.2 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.0 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.0 | GO:0043096 | purine ribonucleoside salvage(GO:0006166) adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.0 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.0 | GO:2001259 | positive regulation of calcium ion transmembrane transporter activity(GO:1901021) positive regulation of cation channel activity(GO:2001259) |
0.0 | 0.3 | GO:0000090 | mitotic anaphase(GO:0000090) |
0.0 | 0.7 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.0 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.0 | 0.1 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.0 | 0.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.1 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.0 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.2 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.0 | 0.1 | GO:0033088 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.0 | 0.7 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 0.1 | GO:0021681 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.0 | 0.0 | GO:0003211 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.0 | 0.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 1.4 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.3 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.0 | GO:0042596 | fear response(GO:0042596) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.0 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.0 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.1 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.3 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.0 | 0.0 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.0 | 0.1 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.1 | GO:0051322 | anaphase(GO:0051322) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.1 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.1 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.0 | 0.0 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.0 | 0.2 | GO:1904376 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.0 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.2 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.2 | GO:0042832 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
0.0 | 0.1 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.0 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.0 | 0.1 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.0 | 0.1 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.0 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.0 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.1 | GO:0060214 | endocardium formation(GO:0060214) |
0.0 | 0.1 | GO:0045117 | azole transport(GO:0045117) |
0.0 | 0.1 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.4 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.0 | 0.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.1 | GO:1902808 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.1 | GO:1901978 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.2 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.0 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.0 | 0.2 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.1 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.0 | 0.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.1 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.0 | 0.2 | GO:0050860 | regulation of T cell receptor signaling pathway(GO:0050856) negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.1 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.1 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.2 | GO:0001662 | behavioral fear response(GO:0001662) |
0.0 | 0.2 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.0 | 0.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.1 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.3 | GO:1903038 | negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.0 | 0.0 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.2 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.1 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.0 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.1 | GO:0021853 | interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
0.0 | 0.1 | GO:0048263 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.0 | 0.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.0 | 0.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.0 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.1 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 0.3 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.1 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.0 | 0.0 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 0.0 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.1 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.0 | 0.0 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.5 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 0.0 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.4 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.0 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.2 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.0 | 0.1 | GO:0048557 | embryonic digestive tract morphogenesis(GO:0048557) |
0.0 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.1 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.0 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.0 | 0.1 | GO:1903393 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
0.0 | 0.3 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 1.6 | GO:0007159 | leukocyte cell-cell adhesion(GO:0007159) |
0.0 | 0.0 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.5 | GO:0006997 | nucleus organization(GO:0006997) |
0.0 | 0.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.0 | 0.0 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.1 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.0 | 0.1 | GO:0051597 | response to methylmercury(GO:0051597) |
0.0 | 0.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.2 | GO:0090114 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.0 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.0 | 0.0 | GO:0072111 | cell proliferation involved in kidney development(GO:0072111) |
0.0 | 0.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.0 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.1 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 0.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.0 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.1 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.0 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.0 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.0 | 0.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.0 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.0 | 0.2 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.0 | 0.1 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.2 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.2 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.0 | 0.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.0 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.2 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.0 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.1 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.0 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.0 | 0.3 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.1 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.1 | GO:2001257 | regulation of calcium ion transmembrane transporter activity(GO:1901019) regulation of cation channel activity(GO:2001257) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.1 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.0 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.0 | 0.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.1 | GO:0098543 | detection of other organism(GO:0098543) |
0.0 | 0.0 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.0 | 0.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.0 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.0 | 0.0 | GO:0021561 | facial nerve development(GO:0021561) |
0.0 | 0.0 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.0 | 0.0 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.1 | GO:0050718 | positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.2 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.0 | 0.3 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.0 | GO:0032375 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.3 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.0 | 0.0 | GO:0032048 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.0 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.0 | 0.0 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.0 | 0.0 | GO:0034110 | regulation of homotypic cell-cell adhesion(GO:0034110) |
0.0 | 0.1 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.0 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 1.1 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.1 | GO:0048710 | regulation of astrocyte differentiation(GO:0048710) |
0.0 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.0 | GO:0051446 | positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.0 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.0 | 0.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.0 | 0.1 | GO:0044321 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.0 | 0.0 | GO:0039703 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.1 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.0 | GO:0010042 | response to manganese ion(GO:0010042) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.2 | GO:0000045 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.0 | 0.2 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.0 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.0 | 0.1 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.0 | 0.1 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.2 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 0.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.0 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.0 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.0 | 0.2 | GO:0051282 | release of sequestered calcium ion into cytosol(GO:0051209) regulation of sequestering of calcium ion(GO:0051282) negative regulation of sequestering of calcium ion(GO:0051283) calcium ion transmembrane import into cytosol(GO:0097553) calcium ion import into cytosol(GO:1902656) |
0.0 | 0.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.6 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.0 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.0 | 0.1 | GO:1903078 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.0 | 0.0 | GO:0045359 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.1 | GO:0006906 | vesicle fusion(GO:0006906) |
0.0 | 0.1 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 0.0 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.0 | 0.0 | GO:0032607 | interferon-alpha production(GO:0032607) regulation of interferon-alpha production(GO:0032647) |
0.0 | 0.0 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.0 | 0.0 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) |
0.0 | 0.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.1 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.0 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.0 | 0.1 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.1 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) |
0.0 | 0.1 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.0 | 0.1 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.0 | GO:0046479 | glycosylceramide catabolic process(GO:0046477) glycosphingolipid catabolic process(GO:0046479) |
0.0 | 0.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.0 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
0.0 | 0.0 | GO:0070265 | necrotic cell death(GO:0070265) |
0.0 | 0.0 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.1 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.0 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.2 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.1 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.3 | GO:0001709 | cell fate determination(GO:0001709) |
0.0 | 0.0 | GO:0090279 | regulation of calcium ion import(GO:0090279) |
0.0 | 0.0 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.2 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.0 | 0.1 | GO:0010039 | response to iron ion(GO:0010039) |
0.0 | 0.0 | GO:0007129 | synapsis(GO:0007129) chromosome organization involved in meiotic cell cycle(GO:0070192) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.3 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.0 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 0.7 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.0 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.0 | 0.0 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.0 | 0.0 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.0 | 0.0 | GO:0048679 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.0 | 0.0 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.0 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.0 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.0 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.0 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.0 | GO:0031342 | negative regulation of cell killing(GO:0031342) |
0.0 | 0.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.0 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.0 | 0.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.0 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.0 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.0 | 0.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.2 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.4 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.0 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.0 | 0.0 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.0 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.1 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.0 | GO:0051307 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.0 | 0.0 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.0 | 0.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.2 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.5 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.1 | 1.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.8 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 0.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.1 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.1 | 0.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.2 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.1 | 0.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.4 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.5 | GO:0032156 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.0 | 0.2 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.0 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.2 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.9 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.0 | 0.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.8 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.5 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 1.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.3 | GO:0030313 | cell envelope(GO:0030313) |
0.0 | 0.1 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.0 | 0.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.7 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.1 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 0.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 2.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.1 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 0.3 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.2 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.1 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 0.3 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.2 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.1 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.2 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.2 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.0 | 0.0 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.0 | 0.3 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.7 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.0 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.9 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.8 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.0 | 0.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.2 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.3 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.0 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.1 | GO:0000803 | sex chromosome(GO:0000803) |
0.0 | 0.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.2 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.0 | 0.1 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.0 | 0.0 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.4 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 1.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.0 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.2 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.8 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.1 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.0 | 0.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.6 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 1.1 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 0.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 0.5 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.1 | 0.4 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.1 | 0.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.2 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.1 | 0.4 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.6 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.3 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 2.7 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.1 | 1.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.1 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 2.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.1 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.1 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.5 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.5 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.4 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.2 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 0.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.3 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.3 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.4 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.2 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 0.2 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.0 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.7 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.2 | GO:0001012 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.0 | 0.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 1.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.5 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.4 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.3 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0016715 | dopamine beta-monooxygenase activity(GO:0004500) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.0 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.0 | 0.0 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 2.9 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 1.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.5 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.0 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.0 | 0.0 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.1 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.0 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.0 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.2 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.4 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.1 | GO:0004396 | hexokinase activity(GO:0004396) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.2 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.1 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.0 | 0.0 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.0 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 0.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.4 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.0 | 0.5 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.1 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.0 | 0.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.7 | GO:0050136 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.2 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.0 | 0.1 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.0 | 0.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.1 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.0 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.0 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.0 | 0.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.0 | 0.5 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.0 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.0 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.0 | 0.4 | GO:0001104 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.0 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.8 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.0 | 0.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.1 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.0 | 0.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.3 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.7 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.0 | 0.3 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.1 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.0 | 0.0 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.0 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.0 | 0.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.0 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.0 | 0.1 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.2 | GO:0005231 | excitatory extracellular ligand-gated ion channel activity(GO:0005231) |
0.0 | 0.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.3 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 2.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.1 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.0 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 0.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 0.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.0 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 1.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 1.8 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 1.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 1.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 1.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 1.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 0.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 1.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.5 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 2.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 2.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 2.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 0.5 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 1.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 1.1 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 1.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.3 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.0 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 1.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.7 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 1.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 2.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.1 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 1.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.8 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 0.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.8 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.0 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.2 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 1.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.0 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.0 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.0 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.2 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.0 | 0.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.3 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.0 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |